Sicart Associates LLC Buys Ionis Pharmaceuticals Inc, Merck Inc, Campbell Soup Co, Sells Invesco China Small Cap, Microsoft Corp, Capital One Financial Corp

• New Purchases: SH, BND, IWF, IWD, VEA,
• Added Positions: IONS, MRK, CPB, PG, INTC, BIL, GLW, NUAN, SHV, FSM,
• Reduced Positions: MSFT, BA, FB, ADP, AMZN, FGEN, SQ, XBI, NTR, OSUR,
• Sold Out: HAO, COF, F, NKTR, TGT, SYF, ROK,

For the details of Sicart Associates LLC's stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Sicart+Associates+LLC

1. Ionis Pharmaceuticals Inc (IONS) - 523,894 shares, 12.04% of the total portfolio. Shares added by 51.06%
2. SPDR Gold Trust (GLD) - 134,584 shares, 8.81% of the total portfolio. Shares reduced by 0.27%
3. Patterson-UTI Energy Inc (PTEN) - 659,595 shares, 6.55% of the total portfolio. Shares reduced by 0.08%
4. Intel Corp (INTC) - 204,538 shares, 5.61% of the total portfolio. Shares added by 62.65%
5. Pioneer Natural Resources Co (PXD) - 37,875 shares, 3.95% of the total portfolio. Shares added by 0.13%

Sicart Associates LLC initiated holding in ProShares Short S&P500. The purchase prices were between $28.68 and $30.99, with an estimated average price of $29.56. The stock is now traded at around $28.47. The impact to a portfolio due to this purchase was 1.6%. The holding were 99,000 shares as of 2018-06-30.

Sicart Associates LLC initiated holding in Vanguard Total Bond Market. The purchase prices were between $78.33 and $79.8, with an estimated average price of $79.06. The stock is now traded at around $79.25. The impact to a portfolio due to this purchase was 0.18%. The holding were 4,141 shares as of 2018-06-30.

Sicart Associates LLC initiated holding in iShares Russell 1000 Growth. The purchase prices were between $132.8 and $148, with an estimated average price of $141.21. The stock is now traded at around $149.34. The impact to a portfolio due to this purchase was 0.16%. The holding were 2,000 shares as of 2018-06-30.

Sicart Associates LLC initiated holding in iShares Russell 1000 Value. The purchase prices were between $117.32 and $124.14, with an estimated average price of $121.6. The stock is now traded at around $123.11. The impact to a portfolio due to this purchase was 0.15%. The holding were 2,317 shares as of 2018-06-30.

Sicart Associates LLC initiated holding in Vanguard FTSE Developed Markets. The purchase prices were between $42.43 and $45.59, with an estimated average price of $44.58. The stock is now traded at around $43.03. The impact to a portfolio due to this purchase was 0.14%. The holding were 5,887 shares as of 2018-06-30.

Sicart Associates LLC added to a holding in Ionis Pharmaceuticals Inc by 51.06%. The purchase prices were between $40.53 and $50.7, with an estimated average price of $44.27. The stock is now traded at around $44.68. The impact to a portfolio due to this purchase was 4.07%. The holding were 523,894 shares as of 2018-06-30.

Sicart Associates LLC added to a holding in Merck & Co Inc by 439.46%. The purchase prices were between $53.27 and $62.59, with an estimated average price of $59.12. The stock is now traded at around $62.87. The impact to a portfolio due to this purchase was 2.45%. The holding were 89,157 shares as of 2018-06-30.

Sicart Associates LLC added to a holding in Campbell Soup Co by 650.12%. The purchase prices were between $33.19 and $43.73, with an estimated average price of $39.01. The stock is now traded at around $40.07. The impact to a portfolio due to this purchase was 2.4%. The holding were 123,770 shares as of 2018-06-30.

Sicart Associates LLC added to a holding in Procter & Gamble Co by 642.97%. The purchase prices were between $70.94 and $79.05, with an estimated average price of $75.29. The stock is now traded at around $78.63. The impact to a portfolio due to this purchase was 2.22%. The holding were 59,579 shares as of 2018-06-30.

Sicart Associates LLC added to a holding in Intel Corp by 62.65%. The purchase prices were between $48.76 and $57.08, with an estimated average price of $53.07. The stock is now traded at around $51.30. The impact to a portfolio due to this purchase was 2.16%. The holding were 204,538 shares as of 2018-06-30.

Sicart Associates LLC added to a holding in SPDR Bloomberg Barclays 1-3 Month T-Bill by 34.11%. The purchase prices were between $91.43 and $91.58, with an estimated average price of $91.5. The stock is now traded at around $91.54. The impact to a portfolio due to this purchase was 0.13%. The holding were 10,025 shares as of 2018-06-30.

Sicart Associates LLC sold out a holding in Invesco China Small Cap. The sale prices were between $28.82 and $33.05, with an estimated average price of $31.39.

Sicart Associates LLC sold out a holding in Capital One Financial Corp. The sale prices were between $87.92 and $98.35, with an estimated average price of $94.65.

Sicart Associates LLC sold out a holding in Ford Motor Co. The sale prices were between $10.82 and $12.11, with an estimated average price of $11.45.

Sicart Associates LLC sold out a holding in Nektar Therapeutics Inc. The sale prices were between $46.25 and $104.45, with an estimated average price of $76.82.

Sicart Associates LLC sold out a holding in Target Corp. The sale prices were between $68.98 and $79.07, with an estimated average price of $73.61.

Sicart Associates LLC sold out a holding in Synchrony Financial. The sale prices were between $32.13 and $36.12, with an estimated average price of $34.35.